欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
NL/H/1455/002
药品名称
Repaglinide Stada 1 mg tablets
活性成分
repaglinide 1.0 mg
剂型
Tablet
上市许可持有人
STADA Arzneimittel AG Germany
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Germany (DE)
Repaglinid STADA 1mg Tabletten
Belgium (BE)
Luxembourg (LU)
Austria (AT)
Edinimel 1 mg Tabletten
France (FR)
Spain (ES)
Italy (IT)
Sweden (SE)
Repaglinid STADA
Finland (FI)
Bulgaria (BG)
Indorin
Romania (RO)
Repaglinidă HF 1 mg comprimate
Slovenia (SI)
许可日期
2009/09/16
最近更新日期
2023/07/10
药物ATC编码
A10BX02 repaglinide
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Product Information
|
nlh1455_56_001_4_R_Updated FRAR_RMS
Date of last change:2024/09/06
Final Product Information
|
PL_Repaglinide_NL1455_20140523_tracked_akkoord
Date of last change:2024/09/06
Final Product Information
|
PL_Repaglinide_NL1456_20140523_tracked_akkoord
Date of last change:2024/09/06
Final Product Information
|
SmPC_Repaglinide_NL1455_20140523_tracked_akkoord
Date of last change:2024/09/06
Final Product Information
|
SmPC_Repaglinide_NL1456_20140523_tracked_akkoord
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase